- increased circulating calcium level / IMPC
- increased circulating insulin level / IMPC
- increased circulating alkaline phosphatase level / IMPC
- abnormal bone structure / IMPC
- decreased lean body mass / IMPC
- impaired glucose tolerance / IMPC
- increased total body fat amount / IMPC
- increased red blood cell distribution width / IMPC
- decreased bone mineral content / IMPC
- increased fasting circulating glucose level / IMPC
C57BL/6N-Atm1Brd Mrap2tm1a(EUCOMM)Wtsi/WtsiBiat
Status | Available to order |
EMMA ID | EM:05973 |
International strain name | C57BL/6N-Atm1Brd Mrap2tm1a(EUCOMM)Wtsi/WtsiBiat |
Alternative name | EPD0424_6_B02 |
Strain type | Targeted Mutant Strains |
Allele/Transgene symbol | Mrap2tm1a(EUCOMM)Wtsi |
Gene/Transgene symbol | Mrap2 |
Disclaimer | Please note that for EUCOMM and KOMP-CSD mice supplied to the scientific community by INFRAFRONTIER/EMMA:
|
Information from provider
Provider | Wellcome Trust Sanger Institute |
Provider affiliation | Wellcome Trust Sanger Institute |
Genetic information | This mouse line originates from EUCOMM ES clone EPD0424_6_B02. For further details on the construction of this clone see the page at the IMPC portal. |
Phenotypic information | Potential phenotyping data in the IMPC portal |
References | None available |
Information from EMMA
Archiving centre | University of Veterinary Medicine, Vienna, Austria |
Disease and phenotype information
IMPC phenotypes (allele matching)
IMPC phenotypes (gene matching)
- abnormal bone structure / IMPC
- impaired glucose tolerance / IMPC
- increased total body fat amount / IMPC
- increased circulating calcium level / IMPC
- decreased bone mineral content / IMPC
- increased fasting circulating glucose level / IMPC
- decreased lean body mass / IMPC
- increased red blood cell distribution width / IMPC
- increased circulating insulin level / IMPC
- increased circulating alkaline phosphatase level / IMPC
MGI phenotypes (gene matching)
- increased brown adipose tissue amount / MGI
- increased body length / MGI
- increased body weight / MGI
- obese / MGI
- polyphagia / MGI
- abnormal intestinal absorption / MGI
- hepatic steatosis / MGI
- decreased lean body mass / MGI
- abnormal adrenaline level / MGI
- abnormal noradrenaline level / MGI
- homeostasis/metabolism phenotype / MGI
- behavior/neurological phenotype / MGI
- increased susceptibility to weight gain / MGI
- increased percent body fat/body weight / MGI
- increased circulating leptin level / MGI
- increased white fat cell size / MGI
- increased total body fat amount / MGI
- increased food intake / MGI
- increased compensatory feeding amount / MGI
Information on how we integrate external resources can be found here
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).